• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 22-Mar-2019
SENSEX
38,164.61
-222.14 (-0.58%)
NIFTY
11,456.90
-64.15 (-0.56%)
    No Companies Visited

Back to news list
  • Zydus Cadila receives USFDA approval for Betamethasone Dipropionate Cream

    Zydus Cadila has received the final approval from the USFDA to market Betamethasone Dipropionate Cream USP (US RLD — DIPROLENE® AF), 0.05%. It will be manufactured at the group's Topical manufacturing facility at Ahmedabad. This medication is a strong corticosteroid and is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Betamethasone reduces the swelling, itching and redness that can occur in these types of conditions. The group also received a final approval for Amlodipine and Atorvastatin Tablets USP (US RLD — Caduet) in the strengths of 2.5 mg/10 mg, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad. This combination product contains two active ingredients - amlodipine and atorvastatin. Amlodipine reduces blood pressure and the workload on the heart by relaxing the walls of the blood vessels. It is used to lower blood pressure and to treat angina (chest pain). Atorvastatin is used in combination with diet and exercise to treat high cholesterol. It works by blocking an enzyme that is needed to make cholesterol in the body.

    Back to news list
Previous Stories :
More
Corporate News

Quick Links

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
91-22-25230011
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine Print Edition queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 22-Mar-2019
  •  ( 16:30) Volatile session ends with loss as bulls take breather   
  •  ( 14:30) Auto shares decline  
  •  ( 14:30) Nifty ends below 11,500 mark  
  •  ( 13:27) Barclays, TCS announce partnership  
  •  ( 11:59) Tata Power SED bags Rs 1200 crore contract  
  •  ( 10:25) Metal shares advance  
  •  ( 10:24) US Fed leaves interest rates unchanged, no hikes in 2019  
  •  ( 10:23) Asia shares slide on global growth concerns  
  •  ( 10:22) Sensex, Nifty extend early gains  
  •  ( 09:51) IDFC First Bank divests 8.37% stake in ARCIL  
  •  ( 08:12) Infosys and Roland-Garros Partner for Digital Innovation  
Show News
22 March 2019 00:00
1470.70
(1.08 %)
757.35
(0.24 %)
2949.40
(0.04 %)
2836.85
(-1.23 %)
331.15
(-0.78 %)
231.95
(-2.21 %)
1984.35
(-0.14 %)
1026.85
(-1.19 %)
2274.85
(-1.06 %)
2605.25
(-0.28 %)
1678.55
(-0.63 %)
391.60
(-0.36 %)
1700.30
(-0.82 %)
742.15
(0.49 %)
297.70
(-0.27 %)
1334.40
(-1.22 %)
1394.00
(1.54 %)
678.65
(-0.18 %)
6558.00
(-1.84 %)
134.05
(3.67 %)
152.55
(0.46 %)
198.50
(0.53 %)
1342.10
(-2.44 %)
298.10
(-1.76 %)
473.15
(-0.25 %)
175.40
(-2.47 %)
86.75
(-2.80 %)
518.15
(0.90 %)
2004.65
(-0.54 %)
173.95
(-0.11 %)
252.50
(0.14 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.